10x Genomics Долг / собственный капитал
Что обозначает Долг / собственный капитал в 10x Genomics?
Долг / собственный капитал 10x Genomics, Inc. является 0.30
Какое определение для Долг / собственный капитал?
Соотношение долга к собственному капиталу - это финансовое соотношение, показывающее относительную пропорцию собственного капитала и долга, используемых для финансирования активов компании.
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
Долг / собственный капитал компаний в Health Care сектор на NASDAQ по сравнению с 10x Genomics
Что делает 10x Genomics?
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Компании с долг / собственный капитал похож на 10x Genomics
- TREX Co имеет Долг / собственный капитал из 0.30
- Softpower International имеет Долг / собственный капитал из 0.30
- Kitex Garments имеет Долг / собственный капитал из 0.30
- Life360 имеет Долг / собственный капитал из 0.30
- Replimune Inc имеет Долг / собственный капитал из 0.30
- Rexahn Pharmaceuticals имеет Долг / собственный капитал из 0.30
- 10x Genomics имеет Долг / собственный капитал из 0.30
- DroneShield имеет Долг / собственный капитал из 0.30
- Eguarantee имеет Долг / собственный капитал из 0.30
- GCL New имеет Долг / собственный капитал из 0.30
- Goldstone Technologies имеет Долг / собственный капитал из 0.30
- Chinese Estates имеет Долг / собственный капитал из 0.30
- CALBEE имеет Долг / собственный капитал из 0.30